2021 has seen a number of macular disease drug developments. Macula Matters has selected a few of the most relevant.
Read More2021 has seen a number of macular disease drug developments. Macula Matters has selected a few of the most relevant.
Read MoreResults have now been presented at medical conferences in the USA.
Read MoreIn the August 2021 Macula Matters, MDFA’s email newsletter for eye health professionals, we launch our CPD course on diabetic eye disease. There’s news on our meeting with the Health Minister plus a CERA case study.
Read MoreIntroducing the Centre for Eye Health, a not-for-profit initiative of Guide Dogs NSW/ACT and UNSW.
Read MoreA case study on different imaging modalities from the Centre for Eye Health
Read MoreIn the May 2021 edition of Macula Matters, MDFA’s email newsletter for eye health professionals, we announce new CPD courses for optometrists.
Read MoreHow Professor Mark Gillies’ ever-expanding digital database helps clinicians across the globe.
Read MoreCase study: A 14-year-old male was referred to CERA with a white-yellow macular lesion and suspicions of an inherited condition.
Read MoreMDFA Patron Ita Buttrose AC OBE calls on Government to reject Medicare eye injection rebate cut.
Read More